乳房筛查增加了乳房切除术的数量。 - Suppr

Suppr

超能文献

Breast screening has increased the number of mastectomies.

作者信息

Dixon J Michael

机构信息

Breakthrough Research Unit, Edinburgh, Edinburgh Breast Unit, Western General Hospital, Edinburgh EH4 2XU, UK.

出版信息

Breast Cancer Res. 2009;11 Suppl 3(Suppl 3):S19. doi: 10.1186/bcr2438. Epub 2009 Dec 18.

DOI:10.1186/bcr2438

PMID:20030870

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2797699/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab5/2797699/641067b85d45/bcr2438-1.jpg

相似文献

Breast screening has increased the number of mastectomies.

Breast Cancer Res. 2009;11 Suppl 3(Suppl 3):S19. doi: 10.1186/bcr2438. Epub 2009 Dec 18.

Breast reduction: is it an aid to cancer detection?

Br J Plast Surg. 1972 Apr;25(2):144-6. doi: 10.1016/s0007-1226(72)80036-5.

[Preoperative diagnosis and histological findings in 51 subcutaneous mastectomies (proceedings)].

Arch Gynakol. 1977 Jul 29;224(1-4):339-40. doi: 10.1007/BF00679591.

Pyoderma gangrenosum of the breast after bilateral simple mastectomies for ductal carcinoma in situ.

Am Surg. 2011 Jul;77(7):E144-6.

Ductal carcinoma in situ of the breast; diagnostic assessment and treatment.

Scand J Surg. 2002;91(3):268-72. doi: 10.1177/145749690209100310.

Subcutaneous mastectomy and immediate prosthetic implantation as an alternative to simple mastectomy.

Can J Surg. 1974 Jan;17(1):63-7.

[Nonpalpable breast cancer].

Vopr Onkol. 1992;38(1):111-3.

Introduction to sessions on guidelines and endocrine therapy, the influence of breast screening on number of mastectomies and the challenge between molecular science and traditional dogma in the treatment of breast cancer. Introduction to Session 6.

Breast Cancer Res. 2009;11 Suppl 3(Suppl 3):S17. doi: 10.1186/bcr2436. Epub 2009 Dec 18.

Delayed Recurrent and Bilateral Breast Cancer in Patients With Partial Poland's Anomaly: Report of 2 Rare Cases and Review of the Literature.

Clin Breast Cancer. 2018 Jun;18(3):e285-e290. doi: 10.1016/j.clbc.2018.01.012. Epub 2018 Feb 21.

Current surgical options in carcinoma of the breast.

Ala Med. 1986 Mar;55(9):20-3.

引用本文的文献

Use of Mastectomy for Overdiagnosed Breast Cancer in the United States: Analysis of the SEER 9 Cancer Registries.

J Cancer Epidemiol. 2019 Jan 22;2019:5072506. doi: 10.1155/2019/5072506. eCollection 2019.

Rational and irrational issues in breast cancer screening.

Cancers (Basel). 2011 Jan 11;3(1):252-66. doi: 10.3390/cancers3010252.

Screening for breast cancer with mammography.

Cochrane Database Syst Rev. 2013 Jun 4;2013(6):CD001877. doi: 10.1002/14651858.CD001877.pub5.

Frank words about breast screening.

Open Med. 2011;5(3):e134-6. Epub 2011 Jul 26.

Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data.

BMJ. 2011 Sep 13;343:d4692. doi: 10.1136/bmj.d4692.

本文引用的文献

Increase in response rate by prolonged treatment with neoadjuvant letrozole.

Breast Cancer Res Treat. 2009 Jan;113(1):145-51. doi: 10.1007/s10549-008-9915-6. Epub 2008 Feb 9.

Histopathology of breast carcinoma following neoadjuvant systemic therapy: a common association between letrozole therapy and central scarring.

Histopathology. 2007 Aug;51(2):219-26. doi: 10.1111/j.1365-2559.2007.02752.x.

DCIS and aromatase inhibitors.

J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):173-9. doi: 10.1016/j.jsbmb.2007.05.015. Epub 2007 May 24.

Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer.

J Clin Oncol. 2007 Apr 1;25(10):1232-8. doi: 10.1200/JCO.2005.05.3306. Epub 2007 Feb 12.

Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary results.

Ann Surg Oncol. 2004 Jan;11(1 Suppl):37S-43S. doi: 10.1007/BF02524794.

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.

Eur J Cancer. 2003 Aug;39(12):1746-54. doi: 10.1016/s0959-8049(03)00260-0.

Molecular markers and therapeutic targets in ductal carcinoma in situ.

Microsc Res Tech. 2002 Oct 1;59(1):3-11. doi: 10.1002/jemt.10172.

Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999.

Cancer. 2000 Feb 15;88(4):946-54.

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

Lancet. 1999 Jun 12;353(9169):1993-2000. doi: 10.1016/S0140-6736(99)05036-9.

Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy.

Cancer. 1995 Oct 1;76(7):1197-200. doi: 10.1002/1097-0142(19951001)76:7<1197::aid-cncr2820760715>3.0.co;2-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验